- Medical gases such as oxygen, nitrous oxide, medical air, and carbon dioxide are essential in patient care for anesthesia, ventilation, diagnostics, and therapy. These gases are administered through high-pressure cylinders or centralized systems and supported by gas equipment like flowmeters, regulators, vacuum systems, and manifolds.
- The growing burden of chronic diseases, increasing number of surgeries, and rising demand for emergency and home-based care are primary drivers. Rapidly aging populations and high pollution levels in urban centers have further pushed oxygen therapy adoption.
- China is the dominant country in the Asia-Pacific medical gas market due to its vast hospital infrastructure, high patient volumes, and government initiatives supporting medical infrastructure modernization.
- India is expected to register the highest CAGR in the region due to rapid urbanization, increased healthcare investments, and national programs promoting access to oxygen and critical care in tier-2 and tier-3 cities.
- Medical oxygen segment is expected to dominate the Asia-Pacific medical gas market with the largest market share of 53.2% due to its critical application in surgical procedures, respiratory illnesses, and emergency care. Increased investment in PSA oxygen plants and oxygen therapy awareness post-COVID further supports its leadership.
